Among surgically resected 74 prostate cancers and 16 normal prostate tissues, ephrin-B2 was induced in 58% (43 out of 74) of the prostate tumors while normal prostate glands showed no expression (Fig. 1a, Supplementary Fig. 1A). Here, EFNB2 is linked to prostate cancer.